NASDAQ · PPCB
Propanc Biopharma, Inc.
$1.93-$0.19 (-8.77%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.4% below the high.
Loading market information…
OTC · PRED · USD
Stock price, earnings
Quote as of Dec 2, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Predictive Technology Group, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Predictive Technology Group, Inc. (PRED), along with its affiliated companies, specializes in the creation and market introduction of cutting-edge molecular diagnostic and therapeutic solutions, as well as human cellular and tissue-based products (HCT/Ps). The company's operations are divided into two primary segments: Human Cellular and Tissue Products (HCT/Ps), and Diagnostics and Therapeutics. PRED offers genetic testing services like FertilityDX, which assists couples experiencing infertility, and ARTguide, a genetic test for women struggling with infertility often linked to endometriosis and other genetic conditions. In the realm of regenerative medicine, its product offerings include AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte. Furthermore, Predictive Technology Group has a cooperative arrangement with Atrin Pharmaceuticals LLC to advance molecular diagnostic tools, which are intended to refine the selection of patients for cancer treatments. Founded in 2005, the company initially operated under the name Global Enterprises Group, Inc., before rebranding to Predictive Technology Group, Inc. in July 2015. Its corporate headquarters are situated in Salt Lake City, Utah.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:28 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.93-$0.19 (-8.77%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.4% below the high.
$0.03$0.00 (0.0%)
TRACON Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.7% below the high.
$0.00-$0.05 (-99.6%)
StatSure Diagnostic Systems, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
Cell Kinetics Ltd.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
PotNetwork Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-25.0%)
Invitae Corporation: Healthcare · Medical - Diagnostics & Research.
$0.00$0.00 (0.0%)
Nexeon MedSystems Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
Health-Chem Corporation: Healthcare · Medical - Diagnostics & Research.
